Cutting-edge rehab programs at the Sue & Bill Gross Stem Cell Research Center utilize robotics and computer software that someday could be combined with stem cell-based therapies to accelerate recovery from strokes and spinal cord injuries.
Aileen Anderson and Brian Cummings of the Sue & Bill Gross Stem Cell Research Center collaborated with StemCells Inc. to develop the treatment for chronic spinal cord injury.
UCI study by radiology oncologist Charles Limoli suggests transplantation of human neural stem cells can alleviate side effects of radiotherapy.
The treatment for people with spinal cord injury was created in the lab of UCI neurobiologist Hans Keirstead.
Paralyzed from the waist down in a car accident last September, Timothy Atchinson now reports some very slight sensation in his legs.
Dr. Henry Klassen is discovering new ways to use stem cells to repair the retina, offering new hope for people suffering from retinitis pigmentosa and macular degeneration.
A therapy developed by Aileen Anderson and Brian Cummings of UC Irvine’s Sue & Bill Gross Stem Cell Research Center in collaboration with researchers at StemCells Inc. will be the basis of the world’s first clinical trial using human neural stem cells to treat spinal cord injury.
California Stem Cell Inc. has applied to the federal Food & Drug Administration to start a Phase I safety study on the treatment, created in collaboration with Hans Keirstead’s research group.
StemCells Inc. has filed an application with the Swiss regulatory agency for therapeutic products to conduct the world’s first clinical study of a human neural stem cell-based treatment in chronic spinal cord injury patients.
The California Institute for Regenerative Medicine grants awarded to Dr. Henry Klassen, Leslie M. Thompson, Brian Cummings and Aileen Anderson will support early stage translational research and help create stem cell treatments for retinitis pigmentosa, Huntington’s disease and traumatic brain injury.